Omers Administration Corp Myriad Genetics Inc Transaction History

Omers Administration Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $819,623 - $1.37 Million	-30,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $1.13 Million - $1.52 Million	30,100 New	30,100 $1.39 Million

228

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

Stay updated on Omers Administration Corp with notifications on news.